This content is restricted.
Brief
The Medicines and Healthcare products Regulatory Agency (MHRA) offers scientific advice to companies at any stage of medicine development, before submitting an application for a marketing authorisation. This includes meetings on pharmacovigilance, advertising, labelling changes, and post-authorisation regulatory advice. Companies can request broader scope scientific advice or joint meetings with MHRA and NICE. The agency will review documentation before the meeting and provide written answers within 30 working days.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
